Document is current
Any future updates will be listed below
-
Authors
Arrobas, A.
Barbosa, M.P.
Rabiais, S.
Vandewalle, B.
Félix, J.
-
Funding
Funding for this research was provided by:
Novartis Pharma AG
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
Journal Title: Pulmonology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2020.03.001
Content Type: article
Copyright: © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
